IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v639y2025i8054d10.1038_s41586-025-08767-9.html
   My bibliography  Save this article

Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Author

Listed:
  • Ferdinandos Skoulidis

    (University of Texas MD Anderson Cancer Center)

  • Haniel A. Araujo

    (University of Texas MD Anderson Cancer Center)

  • Minh Truong Do

    (University of Texas MD Anderson Cancer Center)

  • Yu Qian

    (University of Texas MD Anderson Cancer Center)

  • Xin Sun

    (University of Texas MD Anderson Cancer Center)

  • Ana Galan Cobo

    (University of Texas MD Anderson Cancer Center)

  • John T. Le

    (University of Texas MD Anderson Cancer Center)

  • Meagan Montesion

    (Foundation Medicine)

  • Rachael Palmer

    (Pionyr Immunotherapeutics)

  • Nadine Jahchan

    (Pionyr Immunotherapeutics)

  • Joseph M. Juan

    (D2G Oncology)

  • Chengyin Min

    (Tango Therapeutics)

  • Yi Yu

    (Tango Therapeutics)

  • Xuewen Pan

    (Tango Therapeutics)

  • Kathryn C. Arbour

    (Memorial Sloan Kettering Cancer Center)

  • Natalie Vokes

    (University of Texas MD Anderson Cancer Center)

  • Stephanie T. Schmidt

    (Department of Genomic Medicine and the Institute for Data Science in Oncology, University of Texas MD Anderson Cancer Center)

  • David Molkentine

    (University of Texas MD Anderson Cancer Center)

  • Dwight H. Owen

    (Division of Medical Oncology, Ohio State University–James Comprehensive Cancer Center)

  • Regan Memmott

    (Division of Medical Oncology, Ohio State University–James Comprehensive Cancer Center)

  • Pradnya D. Patil

    (Cleveland Clinic)

  • Melina E. Marmarelis

    (Perelman School of Medicine at the University of Pennsylvania)

  • Mark M. Awad

    (Dana-Farber Cancer Institute)

  • Joseph C. Murray

    (Johns Hopkins University School of Medicine)

  • Jessica A. Hellyer

    (Stanford University)

  • Justin F. Gainor

    (Massachussetts General Hospital)

  • Anastasios Dimou

    (Mayo Clinic)

  • Christine M. Bestvina

    (University of Chicago)

  • Catherine A. Shu

    (Columbia University)

  • Jonathan W. Riess

    (University of California Davis Comprehensive Cancer Center)

  • Collin M. Blakely

    (University of California San Francisco)

  • Chad V. Pecot

    (UNC Lineberger Comprehensive Cancer Center)

  • Laura Mezquita

    (Hospital Clinic de Barcelona)

  • Fabrizio Tabbó

    (Ospedale Michele e Pietro Ferrero)

  • Matthias Scheffler

    (University Hospital Cologne)

  • Subba Digumarthy

    (Massachussetts General Hospital)

  • Meghan J. Mooradian

    (Massachussetts General Hospital)

  • Adrian G. Sacher

    (Princess Margaret Cancer Centre)

  • Sally C. M. Lau

    (NYU Langone Perlmutter Cancer Center)

  • Andreas N. Saltos

    (H. Lee Moffitt Cancer Center)

  • Julia Rotow

    (Dana-Farber Cancer Institute)

  • Rocio Perez Johnson

    (Memorial Sloan Kettering Cancer Center)

  • Corinne Liu

    (Memorial Sloan Kettering Cancer Center)

  • Tyler Stewart

    (University of California San Diego)

  • Sarah B. Goldberg

    (Yale School of Medicine)

  • Jonathan Killam

    (North Shore University Hospital)

  • Zenta Walther

    (Yale School of Medicine)

  • Kurt Schalper

    (Yale School of Medicine)

  • Kurtis D. Davies

    (University of Colorado Anschutz Medical Campus)

  • Mark G. Woodcock

    (UNC Lineberger Comprehensive Cancer Center)

  • Valsamo Anagnostou

    (Johns Hopkins University School of Medicine)

  • Kristen A. Marrone

    (Johns Hopkins University School of Medicine)

  • Patrick M. Forde

    (Johns Hopkins University School of Medicine)

  • Biagio Ricciuti

    (Dana-Farber Cancer Institute)

  • Deepti Venkatraman

    (Dana-Farber Cancer Institute)

  • Eliezer M. Allen

    (Dana-Farber Cancer Institute)

  • Amy L. Cummings

    (David Geffen School of Medicine at the University of California)

  • Jonathan W. Goldman

    (David Geffen School of Medicine at the University of California)

  • Hiram Shaish

    (Columbia University)

  • Melanie Kier

    (Icahn School of Medicine at Mount Sinai)

  • Sharyn Katz

    (Perelman School of Medicine at the University of Pennsylvania)

  • Charu Aggarwal

    (Perelman School of Medicine at the University of Pennsylvania)

  • Ying Ni

    (Cleveland Clinic)

  • Joseph T. Azok

    (Cleveland Clinic)

  • Jeremy Segal

    (University of Chicago)

  • Lauren Ritterhouse

    (Foundation Medicine)

  • Joel W. Neal

    (Stanford University)

  • Ludovic Lacroix

    (Institut Gustave Roussy)

  • Yasir Y. Elamin

    (University of Texas MD Anderson Cancer Center)

  • Marcelo V. Negrao

    (University of Texas MD Anderson Cancer Center)

  • Xiuning Le

    (University of Texas MD Anderson Cancer Center)

  • Vincent K. Lam

    (Johns Hopkins University School of Medicine)

  • Whitney E. Lewis

    (University of Texas MD Anderson Cancer Center)

  • Haley N. Kemp

    (University of Texas MD Anderson Cancer Center)

  • Brett Carter

    (University of Texas MD Anderson Cancer Center)

  • Jack A. Roth

    (University of Texas MD Anderson Cancer Center)

  • Stephen Swisher

    (University of Texas MD Anderson Cancer Center)

  • Richard Lee

    (University of Texas MD Anderson Cancer Center)

  • Teng Zhou

    (University of Texas MD Anderson Cancer Center)

  • Alissa Poteete

    (University of Texas MD Anderson Cancer Center)

  • Yifan Kong

    (University of Texas MD Anderson Cancer Center)

  • Tomohiro Takehara

    (University of Texas MD Anderson Cancer Center)

  • Alvaro Guimaraes Paula

    (University of Texas MD Anderson Cancer Center)

  • Edwin R. Parra Cuentas

    (University of Texas MD Anderson Cancer Center)

  • Carmen Behrens

    (University of Texas MD Anderson Cancer Center)

  • Ignacio I. Wistuba

    (University of Texas MD Anderson Cancer Center)

  • Jianjun Zhang

    (University of Texas MD Anderson Cancer Center)

  • George R. Blumenschein

    (University of Texas MD Anderson Cancer Center)

  • Carl Gay

    (University of Texas MD Anderson Cancer Center)

  • Lauren A. Byers

    (University of Texas MD Anderson Cancer Center)

  • Don L. Gibbons

    (University of Texas MD Anderson Cancer Center)

  • Anne Tsao

    (University of Texas MD Anderson Cancer Center)

  • J. Jack Lee

    (University of Texas MD Anderson Cancer Center)

  • Trever G. Bivona

    (University of California San Francisco)

  • D. Ross Camidge

    (University of Colorado Cancer Center)

  • Jhannelle E. Gray

    (H. Lee Moffitt Cancer Center)

  • Natasha B. Leighl

    (Princess Margaret Cancer Centre)

  • Benjamin Levy

    (Johns Hopkins University School of Medicine)

  • Julie R. Brahmer

    (Johns Hopkins University School of Medicine)

  • Marina C. Garassino

    (University of Chicago)

  • David R. Gandara

    (University of California Davis Comprehensive Cancer Center)

  • Edward B. Garon

    (David Geffen School of Medicine at the University of California)

  • Naiyer A. Rizvi

    (Synthekine)

  • Giorgio Vittorio Scagliotti

    (University of Turin)

  • Jürgen Wolf

    (University Hospital Cologne)

  • David Planchard

    (Institut Gustave Roussy)

  • Benjamin Besse

    (Institut Gustave Roussy)

  • Roy S. Herbst

    (Yale School of Medicine)

  • Heather A. Wakelee

    (Stanford University)

  • Nathan A. Pennell

    (Cleveland Clinic)

  • Alice T. Shaw

    (Novartis Institute for Biomedical Research)

  • Pasi A. Jänne

    (Dana-Farber Cancer Institute)

  • David P. Carbone

    (Division of Medical Oncology, Ohio State University–James Comprehensive Cancer Center)

  • Matthew D. Hellmann

    (AstraZeneca)

  • Charles M. Rudin

    (Memorial Sloan Kettering Cancer Center)

  • Lee Albacker

    (Foundation Medicine)

  • Helen Mann

    (AstraZeneca)

  • Zhou Zhu

    (AstraZeneca)

  • Zhongwu Lai

    (AstraZeneca)

  • Ross Stewart

    (AstraZeneca)

  • Solange Peters

    (Lausanne University)

  • Melissa L. Johnson

    (Sarah Cannon Research Institute, Tennessee Oncology)

  • Kwok K. Wong

    (NYU Langone Perlmutter Cancer Center)

  • Alan Huang

    (Tango Therapeutics)

  • Monte M. Winslow

    (D2G Oncology
    Stanford University)

  • Michael J. Rosen

    (D2G Oncology)

  • Ian P. Winters

    (D2G Oncology)

  • Vassiliki A. Papadimitrakopoulou

    (Pfizer)

  • Tina Cascone

    (University of Texas MD Anderson Cancer Center)

  • Philip Jewsbury

    (AstraZeneca)

  • John V. Heymach

    (University of Texas MD Anderson Cancer Center)

Abstract

No abstract is available for this item.

Suggested Citation

  • Ferdinandos Skoulidis & Haniel A. Araujo & Minh Truong Do & Yu Qian & Xin Sun & Ana Galan Cobo & John T. Le & Meagan Montesion & Rachael Palmer & Nadine Jahchan & Joseph M. Juan & Chengyin Min & Yi Yu, 2025. "Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors," Nature, Nature, vol. 639(8054), pages 19-19, March.
    • Handle: RePEc:nat:nature:v:639:y:2025:i:8054:d:10.1038_s41586-025-08767-9
    DOI: 10.1038/s41586-025-08767-9
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41586-025-08767-9
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/s41586-025-08767-9?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:639:y:2025:i:8054:d:10.1038_s41586-025-08767-9. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.